Fundraising Fox
Melbourne · Seed · 1 people tracked
Find your way into Brandon BioCatalyst
Sign up to see every warm intro you have to Brandon BioCatalyst
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Brandon BioCatalyst team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Brandon BioCatalyst focuses on translating medical science from research into commercial ventures across the life sciences. Rather than acting purely as a capital provider, it uses a hands-on venture model, partnering with entrepreneurs to build and operate companies. Its interests span cancer, molecular bioscience, metabolic and musculoskeletal medicine, infection and immunity, and broader biotech and medtech innovations. Backed by a collaboration of superannuation funds, CSL, national and state governments, and medical research institutes, the fund aims to accelerate medical innovation and bring novel therapeutics and diagnostics to patients.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's website
What they invest in
from 7 of 11 portfolio companiesBiotech ×6Healthtech ×6Medical Devices ×6Deep Tech ×2Digital Health ×2FemTech ×1Longevity ×1
HQs:Australia×5United States×3
Investments · 11 tracked
founders shown can be your intro path
George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health.
BiotechDigital HealthHealthtechMedical Devices
Mark Mallon(Chief Executive Officer)inProfessor Anthony Rodgers(Chief Medical Officer)Dr Karl Roberts(Chief Operating Officer)in
Co-investorsBrandon CapitalBrandon Capital Partners
Q-Sera is a biotech company backed by Australian investors Uniseed and Brandon BioCatalyst, emerging from University of Queensland commercialisation efforts.
BiotechHealthtechMedical DevicesBrisbane, AU
Michael Grant(Chief Executive Officer)in
Co-investorsStoic VCUniSeed Pty Ltd.
ENA Respiratory develops and brings respiratory treatments to market across the US and other regions.
BiotechHealthtechMedical DevicesMelbourne, AU
Co-investorsBrandon CapitalStoic VCUniSeed Pty Ltd.
Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity.
BiotechDeep TechDigital HealthHealthtechLongevityBaltimore, US
Ashish Nimgaonkar(Executive Officer, Director)Dennis McWilliams(Director)inCasey Cunningham(Director)Leighton Read(Director)inBob Soh(Director)in
Co-investorsBrandon Capital PartnersBreakout Labs
An online gambling platform licensed under Curacao eGaming, offering video slots, live dealer tables, progressive jackpots, and specialty games from studios such as NetEnt, Microgaming, and Pragmatic Play.
Co-investorsStoic VCBrandon Capital Partners
OncoRes Medical develops an intraoperative imaging technology that combines optical coherence tomography (OCT) and elastography to give surgeons real-time assessment of tissue microstructure at a resolution comparable to histology.
Deep TechHealthtechMedical DevicesPerth, AU
Co-investorsRadar Ventures
Brandon Capital is a venture capital firm that transforms medical research breakthroughs into therapeutic products, supporting life science companies from early-stage through commercialization.
BiotechMedical DevicesSan Francisco, US
Co-investorsBrandon Capital PartnersAirTree VenturesGolden Gate VenturesLINE Ventures
QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy.
BiotechFemTechHealthtechMedical DevicesAtlanta, US
Co-investorsStoic VC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
DentericKraken CodingQUE Oncology
Portfolio news
latest coverage across their companiesOncoRes Medical · finsmes.com · Feb 12, 2026
Frequently asked questions
- How many investments has Brandon BioCatalyst made?
- Brandon BioCatalyst has 11 tracked investments.
- What stage does Brandon BioCatalyst invest at?
- Brandon BioCatalyst invests at the Seed stage.
- What sectors does Brandon BioCatalyst focus on?
- Brandon BioCatalyst focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Brandon BioCatalyst located?
- Brandon BioCatalyst is headquartered in Melbourne, AU.
- Does Brandon BioCatalyst lead rounds?
- Yes, Brandon BioCatalyst leads investment rounds.
- Who does Brandon BioCatalyst co-invest with?
- Brandon BioCatalyst most often shares deals with Stoic VC, Brandon Capital, Brandon Capital Partners, among 5 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.